“In Conversation” with Mina Izadjoo, President of IPS

Published on : Published by : Sarah Ellinwood

“In Conversation” with Mina Izadjoo, President of IPS In preparation for the upcoming CEO Talks Panel on Innovators Combating Drug Resistance, BioBuzz Contributor, Sarah Ellinwood, Ph.D. caught up with one of the panelists, President and CSO of Integrated Pharma Services (IPS), Dr. Mina Izadjoo for a preliminary “In Conversation” interview. What is your background and [….]

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance

Carol Nacy, Ph.D.
Published on : Published by : Steven Surdez

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance  For Dr. Carol Nacy, co-founder and CEO of Rockville, Maryland’s clinical-stage antibiotics developer Sequella, it all started with a fascination for things unseen. “At Catholic University a few wonderful biology professors introduced me to this amazing world of invisible life that [….]